Cyberknife: Clinical Trials

41 trials of Cyberknife, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 9 unknown, 5 terminated, 4 withdrawn. 22 Not applicable, 13 Phase 2, 3 Phase 1, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 14, Withdrawn 3, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 213Completed 7, Unknown 4, Terminated 2
Phase 13Terminated 2, Unknown 1
Early Phase 11Unknown 1
Phase 31Withdrawn 1

Follow Cyberknife: new trials by email Literature Review of Cyberknife trials Research Report on Cyberknife

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
Cyberknife - Pancreas Adenocarcinoma
Not applicableRecruitingCapital Health System, Inc102021-06-222023-03-31
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
Stereotactic Body Radiotherapy - Metastatic Nonsmall Cell Lung Cancer, Non Small Cell Lung Cancer
Phase 2CompletedCrozer-Keystone Health System32017-04-282023-03-06
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Stereotactic Body Radiation Therapy (SBRT) radiation for prostate cancer utilizing the Elekta Versa or Agility System. - Prostate Cancer
Not applicableActive not recruitingHoag Memorial Hospital Presbyterian1002016-10-212025-09-15
Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife
CyberKnife - Pancreatic Tumor
Not applicableCompletedChanghai Hospital162016-03-012021-05-14
Stereotactic Radiosurgery for Soft Tissue Sarcoma
CyberKnife - Soft Tissue Sarcoma
Not applicableWithdrawnThe Cooper Health System2015-06-012024-03-15
Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma
Cyberknife - Prostate Cancer
UnknownCentre Francois Baclesse, Luxembourg262015-01-012022-06-22
An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease
Radiosurgical thalamotomy, CyberKnife - Parkinson Disease
Phase 2UnknownMaria Sklodowska-Curie National Research Institute of Oncology272015-01-012015-04-02
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
Gemcitabine, nab-paclitaxel, CyberKnife - Pancreas Cancer, Pancreatic Cancer
Phase 1TerminatedThe Cooper Health System302015-01-012019-07-30
Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife
CyberKnife - Liver Neoplasms
Phase 2UnknownTianjin Medical University Cancer Institute and Hospital1172014-05-012016-10-07
Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer
Stereotactic body radiotherapy (SBRT) - Breast Neoplasm
Phase 1UnknownJuravinski Cancer Center322014-02-012015-03-31
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
CyberKnife, Androgen Deprivation Therapy (ADT), Intensity Modulated radiation therapy (IMRT) - Prostate Adenocarcinoma
Not applicableCompletedWake Forest University Health Sciences832013-11-192024-10-03
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Irinotecan, CyberKnife - Colorectal Cancer
Not applicableWithdrawnWake Forest University Health Sciences2013-10-012024-10-04
Fractionated Stereotactic Radiosurgery for Large Brain Metastases
Fractionated Stereotactic Radiosurgery - Large Brain Mets
Not applicableCompletedSteven Burton202013-07-162025-05-28
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN
SBRT, Cetuximab, Docetaxel - Previously-Irradiated, Squamous Cell Carcinoma of the Head and Neck Cancer
Phase 2CompletedHeath Skinner402013-07-032023-06-05
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
CyberKnife - Renal Cell Carcinoma
Not applicableUnknownBeth Israel Deaconess Medical Center462013-07-012024-08-15
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation
Stereotactic Radiosurgery (SRS), Chemotherapy - Oligometastatic Disease
Phase 2TerminatedSteven Burton242013-06-072023-10-11
The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife
Radiotherapy - Prostate Cancer
Phase 2UnknownRoyal Marsden NHS Foundation Trust202013-06-012014-05-23
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma
Stereotactic Body Radiation Therapy (SBRT) - Adenocarcinoma of the Pancreas
Not applicableCompletedDavid A. Clump, MD, PhD502013-02-062021-11-24
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Gemcitabine, Stereotactic Radiosurgery - Pancreas Cancer, Pancreatic Cancer
Early Phase 1UnknownThe Cooper Health System152013-01-012016-03-14
Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Stereotactic Radiosurgery, Erlotinib - Non Small Cell Lung Cancer
Phase 2CompletedUNC Lineberger Comprehensive Cancer Center322012-12-112021-01-12

Showing 20 of 41. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (8)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Pancreatic Neoplasms (5)  ·  Carcinoma, Hepatocellular (4)  ·  Liver Neoplasms (4)  ·  Lung Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Head and Neck Neoplasms (2)  ·  Snyder Robinson syndrome (2)  ·  Adrenal Gland Neoplasms (1)  ·  Bone Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Colonic Neoplasms (1)

Sponsors

Accuray Incorporated (3)  ·  Beth Israel Deaconess Medical Center (3)  ·  Steven Burton (3)  ·  The Cooper Health System (3)  ·  Wake Forest University Health Sciences (3)  ·  Community Cancer Center, Normal, Illinois (2)  ·  David A. Clump, MD, PhD (2)  ·  Stanford University (2)  ·  UNC Lineberger Comprehensive Cancer Center (2)  ·  Adam Olson (1)  ·  Albert Koong (1)  ·  Boston Medical Center (1)  ·  Capital Health System, Inc (1)  ·  Centre Francois Baclesse, Luxembourg (1)  ·  Centre Oscar Lambret (1)

Countries

United States (33)  ·  China (3)  ·  United Kingdom (2)  ·  Canada (1)  ·  France (1)  ·  Luxembourg (1)  ·  Poland (1)

Top investigators

David A Clump, MD (3)  ·  Anand Mahadevan, MD (2)  ·  Arica Hirsch, MD (2)  ·  Shermian Woodhouse, MD (2)  ·  Steve Burton, MD (2)  ·  Adam Olson, MD (1)  ·  Albert Koong (1)  ·  Andrew Gaya (1)  ·  Aya Kamaya (1)  ·  Billy W Loo, Jr, MD, PhD (1)  ·  Do-Hoon Kim, BASc, MD, MSc, FRCPC (1)  ·  Donald B Fuller, MD (1)  ·  Dwight E Heron, MD (1)  ·  Edward S James, M.D. (1)  ·  George Mardirossian, PhD (1)

Results publications

PMID 12192016, PMID 12393820, PMID 16360786, PMID 28069017, PMID 2990668, PMID 30003996, PMID 30191864, PMID 34405577, PMID 35387414